Explanipedia

Prognostic relevance of arrhythmic and <span>QTc</span> burden in takotsubo cardiomyopathy: A systematic review and meta‐analysis Open

Ankit Hanmandlu, Jyothik Varun Inampudi, Mohammad Hamza, Prakash Upreti, Yasemin Bahar , et al. · 2025

Introduction Takotsubo cardiomyopathy is characterized by stress‐induced systolic dysfunction of the left ventricle that is largely reversible and not related to coronary ischemia. Patients with Takotsubo cardiomyopathy can often develop c…

C-8 | The Effect of Opioid Use on Outcomes Following PCI in an Urban Tertiary Care Center Open

Azka Naeem, Shaunak Mangeshkar, Mohammad Hamza, Muhammad Hashim Khan, Chmsalddin Alkhas , et al. · 2025

D-64 | Impact of Single Stent vs Multiple Stent Treatment of Culprit Lesion on Post-PCI Outcomes in an Urban Center Open

Rohit Goru, Mohammad Hamza, Ankit Hanmandlu, Bourann Husainy, Anisha R. Pareddy , et al. · 2025

D-68 | The Immediate Impact of Escalation to High-Intensity Statin Therapy In Post-PCI Patients Open

Bourann Husainy, Abdul Rasheed Bahar, Chmsalddin Alkhas, Bassam Al Haly, Ammar Rayes , et al. · 2025

D-80 | Impact of Cocaine Use on Outcomes Post-PCI in an Urban Tertiary Care Center Open

Shaunak Mangeshkar, Mohammad Hamza, Chmsalddin Alkhas, Bassam Al Haly, Abdullah Rayes , et al. · 2025

D-66 | Mid Term Outcomes of PCI Guided with Intravascular Ultrasound versus Angiography Alone in Acute Coronary Syndrome within an Urban Center Open

Ankit Hanmandlu, Jawad Basit, Mohammad Hamza, Bourann Husainy, Aveen Salar , et al. · 2025

D-89 | The Impact of Diabetes Mellitus on Restenosis and Target Lesion Revascularization Following Percutaneous Coronary Intervention Open

Yasaman Navari, Mohammad Hamza, Amir Behzad Bagheri, Yasemin Bahar, Chmsalddin Alkhas , et al. · 2025

D-61 | Impact of Vascular Access Site (Radial vs. Femoral) on Post-PCI Morbidity, Mortality and Outcomes: A Comparative Analysis Open

Amir Behzad Bagheri, Mohammad Hamza, Nouraldeen Manasrah, Yasaman Navari, Yasemin Bahar , et al. · 2025

B-115 | Sex-Based Differences in PCI Outcomes: Lower Procedural Complications Despite Greater Comorbidities in Women Open

Abubakr Ziaullah, Abdel-Rhman Mohamed, Abdul Rasheed Bahar, Chmsalddin Alkhas, Mohammad Akkawi , et al. · 2025

A-75 | Impact of Pulmonary Hypertension on Outcomes Post PCI in an Urban Tertiary Care Center Open

Shaunak Mangeshkar, Mohammad Hamza, Mohammad Akkawi, Chmsalddin Alkhas, Bassam Al Haly , et al. · 2025

C-7 | The Effect of Marijuana Use on Outcomes Following PCI in an Urban Tertiary Care Center Open

Azka Naeem, Shaunak Mangeshkar, Mohammad Hamza, Muhammad Hashim Khan, Chmsalddin Alkhas , et al. · 2025

D-94 | The Impact of Preoperative P2Y12 Inhibitors on Short- and Long-Term Outcomes Following Percutaneous Coronary Intervention Open

Prakruti Patel, Yasemin Bahar, George G. Kidess, Jawad Basit, Chmsalddin Alkhas , et al. · 2025

D-55 | Impact of Type of Access Site on Procedural Outcomes of Percutaneous Coronary Intervention in an Urban Center Open

Hafeezuddin Ahmed, Mohammad Hamza, Syed Sohail Ali, Chmsalddin Alkhas, Bassam Al Haly , et al. · 2025

D-106 | Impact of Insurance Type on Percutaneous Coronary Intervention Outcomes: A Retrospective Analysis of Mortality, Re-intervention, and Recurrent ACS Open

Abubakr Ziaullah, Muhammad Taimur, Mohammad Hamza, Abdel-Rhman Mohamed, Zubi Danish , et al. · 2025

D-65 | Mid-Term Outcomes of PCI in De-Novo Lesions versus In-Stent Restenosis in an Urban Center Open

Ankit Hanmandlu, Yasemin Bahar, Mohamad Hasan Jawadi, Abubakr Ziaullah, Ishaq Khoury , et al. · 2025

D-50 | Racial Disparities in PCI Outcomes: Length of Stay Influenced by Comorbidities Rather Than Race Open

Abubakr Ziaullah, Abdel-Rhman Mohamed, Abdul Rasheed Bahar, Chmsalddin Alkhas, Ishaq Khoury , et al. · 2025

D-81 | Impact of Pre-PCI Troponin Levels on Outcomes Post-PCI in an Urban Tertiary Care Center Open

Shaunak Mangeshkar, Mohammad Hamza, Yasemin Bahar, Jawad Basit, Chmsalddin Alkhas , et al. · 2025

A-12 | Impact of Previous Percutaneous Coronary Intervention (PCI) on PCI Outcomes in an Urban Center Open

Hafeezuddin Ahmed, Abdul Rasheed Bahar, Mohammad Akkawi, Chmsalddin Alkhas, Mohamad Hasan Jawadi , et al. · 2025

D-67 | Long-Term Impact of Escalation to High-Intensity Statin Therapy In Post-PCI Patients Open

Bourann Husainy, Yasemin Bahar, Abubakr Ziaullah, Mohamad Hasan Jawadi, Ishaq Khoury , et al. · 2025

D-54 | Impact of PCI on Both Culprit and Non-culprit lesions Vs. PCI on Culprit-Only Lesions on Outcomes in an Urban Center Open

Hafeezuddin Ahmed, Mohammad Hamza, Jawad Basit, Chmsalddin Alkhas, Bassam Al Haly , et al. · 2025

Diagnostic and Prognostic Value of RV Strain Defined as RV/LV Ratio on Chest CT in Acute Pulmonary Embolism: A Systematic Review Open

Ankit Hanmandlu, Aniruddh Mannari, Aiden Abidov · 2025

Background Pulmonary embolism (PE) is a common cause of acute RV enlargement (often described as RV strain or RV‐S), with significant associated mortality and morbidity. Chest CT pulmonary angiography is a widely available diagnostic modal…

Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: a case series and review of the literature Open

John Cuenca, Ankit Hanmandlu, Robert Wegner, Joshua Botdorf, Sudhakar Tummala , et al. · 2023

Background Checkpoint inhibitor-induced overlap syndrome ([OS] myocarditis, and myositis with or without myasthenia gravis) is rare but life-threatening. Cases presentation Here we present a case series of four cancer patients that develop…

MACHINE LEARNING AND BIOIMPEDANCE TO DRIVE CLINICAL DECISION-MAKING AT HOME: A PROPOSED MODEL TO PREDICT HEART FAILURE EXACERBATIONSAUTHORS Open

Vamsi Maturi, Ankit Hanmandlu, Nidhish Lokesh, Swati Gupta, Tom Valikodath · 2023

Therapeutic Area: Heart Failure Background: Heart failure (HF) exacerbations lead to an estimated 1 million congestive heart failure (CHF)-related admissions annually, costing between $11-15,667 with a hospital stay of 7-21 days. The etiol…

Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19 Open

Dereddi Raja Reddy, John Cuenca, Joshua Botdorf, Mayoora Muthu, Ankit Hanmandlu , et al. · 2022

Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: A case series Open

John Cuenca, Ankit Hanmandlu, Robert Wegner, Joshua Botdorf, Sudhakar Tummala , et al. · 2022

Purpose: To describe the diagnostic approach and management of respiratory failure secondary to the checkpoint inhibitor-induced overlap syndrome. Methods: A retrospective case series of cancer patients receiving treatment with checkpoint …

Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS) Open

Lucy Revercomb, Ankit Hanmandlu, Nancy Wareing, Bindu Akkanti, Harry Karmouty‐Quintana · 2021

Background: Acute respiratory distress syndrome (ARDS) is a severe and often fatal disease. The causes that lead to ARDS are multiple and include inhalation of salt water, smoke particles, or as a result of damage caused by respiratory vir…

Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema Open

Scott D. Collum, Jose G. Molina, Ankit Hanmandlu, Weizhen Bi, Mesias Pedroza , et al. · 2019

Combined pulmonary fibrosis and emphysema (CPFE) is a syndrome that predominantly affects male smokers or ex-smokers and it has a mortality rate of 55% and a median survival of 5 years. Pulmonary hypertension (PH) is a frequently fatal com…

Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension Open

Tinne C. J. Mertens, Ankit Hanmandlu, Ly Tu, Carole Phan, Scott D. Collum , et al. · 2018

Background: Pulmonary hypertension (PH) is a devastating and progressive disease characterized by excessive proliferation of pulmonary artery smooth muscle cells (PASMCs) and remodeling of the lung vasculature. Adenosine signaling t…

Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis Open

Scott D. Collum, Ning‐Yuan Chen, Adriana M. Hernandez, Ankit Hanmandlu, Heather Sweeney , et al. · 2017

Background and Purpose Group III pulmonary hypertension (PH) is a highly lethal and widespread lung disorder that is a common complication in idiopathic pulmonary fibrosis (IPF) where it is considered to be the single most significant pred…

Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives Open

Scott D. Collum, Javier Amione‐Guerra, A.S. Cruz-Solbes, Amara DiFrancesco, Adriana M. Hernandez , et al. · 2017

Pulmonary hypertension (PH) is commonly present in patients with chronic lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) or Idiopathic Pulmonary Fibrosis (IPF) where it is classified as Group III PH by the World Health O…

Ankit Hanmandlu YOU? Author Swipe